CEA IHC

This test detects the expression of CEA in various adenocarcinomas and helps diagnose and monitor colorectal, lung, and breast cancers. It provides valuable information about the presence and extent of these cancers.

• Diagnosing adenocarcinomas, such as colorectal, lung, and breast cancers
• Determining the prognosis of these cancers
• Assessing the effectiveness of treatment
• Detecting cancer recurrence or metastasis
• Guiding further management decisions

Your doctor may recommend this test if you:

• Have been diagnosed with adenocarcinomas
• Need to assess the effectiveness of treatment for these cancers
• Show symptoms suggestive of these cancers
• Require further evaluation based on other diagnostic tests or medical history

Abnormal results of a CEA IHC test can indicate the presence of cancer cells in the tissue sample. The intensity and pattern of CEA staining can provide further information about the type and extent of the cancer. Consult your doctor to interpret the results in the context of your medical history and additional tests.

• Your doctor will collect a tissue sample from a previous biopsy or procedure.
• The sample will be processed and stained using specialised techniques.
• An expert pathologist will analyse the sample for CEA expression and provide a detailed report.
• This is a non-invasive test that does not require any special preparation or discomfort for the patient.

No specific preparation is required for this test. However, it is essential to provide your doctor with relevant clinical and radiological information, including the original histopathology report and any other relevant details. Follow any instructions given by your healthcare provider regarding fasting or medication usage.

• Molecular testing: To detect specific genetic mutations or alterations related to the cancer type being evaluated
• Imaging tests like CT scans, MRIs, or PET scans: To assess the extent of cancer spread and aid in treatment planning
• Blood tests: To measure tumour markers or assess overall health status

• Immunohistochemistry for Carcinoembryonic Antigen (CEA)

Adenocarcinoma is a type of cancer that originates in glandular cells. It can occur in various organs, such as the colon, lung, breast, pancreas, and prostate. Adenocarcinomas are usually diagnosed using biopsy samples and can have different treatment approaches depending on the affected organ.